Branka Bonaci-Nikolic Selected Research

Branka Bonaci-Nikolic Research Topics

Disease

6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2022 - 01/2012
4	Fever (Fevers) 01/2015 - 01/2002
3	Hypersensitivity (Allergy) 08/2021 - 01/2005
3	Vasculitis (Vasculitides) 06/2017 - 01/2005
3	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 11/2013 - 01/2002
3	Infections 01/2012 - 09/2006
3	Microscopic Polyangiitis 01/2006 - 01/2002
2	Alopecia Areata 11/2019 - 09/2015
2	Sepsis (Septicemia) 06/2017 - 01/2009
2	Edema (Dropsy) 01/2015 - 07/2013
2	Exanthema (Rash) 01/2015 - 01/2009
2	Vascular Skin Diseases 07/2013 - 09/2012
2	Purpura 07/2013 - 01/2012
2	Celiac Disease (Celiac Sprue) 04/2012 - 05/2009
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2012 - 08/2010
2	Inflammation (Inflammations) 11/2011 - 01/2002
2	Glomerulonephritis 08/2010 - 01/2006
1	Anaphylaxis (Anaphylactic Shock) 08/2021
1	Bites and Stings (Sting) 08/2021
1	Insect Bites and Stings (Insect Bite) 08/2021
1	Disease Progression 11/2019
1	Splenomegaly 01/2016
1	Primary Immunodeficiency Diseases 01/2016
1	Common Variable Immunodeficiency 01/2016
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2016
1	Arthritis (Polyarthritis) 01/2015
1	Myocarditis (Carditis) 01/2015
1	Cardiogenic Shock 01/2015
1	Mevalonate Kinase Deficiency 01/2015
1	Cytopenia 11/2013
1	Necrosis 11/2013
1	Hoarseness 07/2013
1	Sinusitis 07/2013
1	Exophthalmos (Proptosis) 07/2013
1	Tuberculosis (Tuberculoses) 01/2012
1	Hyperthyroidism 01/2012
1	Ulcerative Colitis 11/2011
1	Sclerosing Cholangitis 11/2011
1	Persistent Infection 08/2010
1	Cryoglobulinemia 08/2010
1	Multiple Myeloma 05/2009
1	Monoclonal Gammopathy of Undetermined Significance 05/2009
1	Eosinophilia 01/2009
1	Drug Hypersensitivity Syndrome 01/2009
1	Leukocytosis (Pleocytosis) 01/2009
1	Systemic Vasculitis 01/2005
1	Autoimmune Diseases (Autoimmune Disease) 01/2005
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2005
1	Rapidly progressive glomerulonephritis with pulmonary hemorrhage 01/2005
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2002
1	Thrombosis (Thrombus) 01/2002

Drug/Important Bio-Agent (IBA)

9	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/2022 - 01/2002
4	AutoantibodiesIBA 01/2016 - 01/2012
4	Pharmaceutical PreparationsIBA 01/2015 - 01/2005
3	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2002
3	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 01/2012
3	AntibodiesIBA 11/2013 - 09/2006
3	Peroxidase (Myeloperoxidase)IBA 01/2012 - 01/2006
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2019 - 09/2015
2	AutoantigensIBA 11/2019 - 01/2012
2	Deoxyribonucleases (DNase)FDA Link 11/2016 - 05/2013
2	CryoglobulinsIBA 09/2012 - 08/2010
2	Propylthiouracil FDA Link 09/2012 - 01/2012
2	Immunoglobulin G (IgG)IBA 01/2012 - 05/2009
2	AntigensIBA 11/2011 - 05/2009
1	LactoferrinIBA 03/2022
1	AllergensIBA 08/2021
1	Arthropod VenomsIBA 08/2021
1	Immunoglobulin E (IgE)IBA 08/2021
1	Rituximab (Mabthera)FDA Link 06/2017
1	SS-A antigen (Ro antigen)IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	CytokinesIBA 01/2016
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2015
1	Histones (Histone)IBA 11/2013
1	Nucleosomes (Nucleosome)IBA 11/2013
1	anti-dsDNA autoantibodyIBA 11/2013
1	Complement C4 (Complement Component 4)IBA 11/2013
1	cryofibrinogenIBA 11/2013
1	Immunoglobulins (Immunoglobulin)IBA 07/2013
1	Deoxyribonuclease I (Nickase)IBA 05/2013
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 04/2012
1	bactericidal permeability increasing proteinIBA 01/2012
1	ImmunosorbentsIBA 01/2012
1	EnzymesIBA 01/2012
1	Pancreatic Elastase (Elastase)IBA 01/2012
1	Peptide Hydrolases (Proteases)FDA Link 11/2011
1	Proteins (Proteins, Gene)FDA Link 11/2011
1	Myeloblastin (Proteinase 3)IBA 08/2010
1	GliadinIBA 05/2009
1	Immunoglobulin A (IgA)IBA 05/2009
1	Toxic ActionsIBA 05/2009
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2009
1	ProcalcitoninIBA 01/2009
1	Antithyroid Agents (Antithyroid Drugs)IBA 01/2005
1	Methimazole (Thiamazole)FDA LinkGeneric 01/2005
1	Antiphospholipid AntibodiesIBA 01/2002

Therapy/Procedure

4	Therapeutics 11/2019 - 09/2015
1	Plasma Exchange 06/2017